Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
59
Number of overlapping holdings
92.2%
% of XLV's 65 holdings also in IYH
53.6%
% of IYH's 113 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus IYH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in IYH |
Overlap | |
|---|---|---|---|---|
 |
UNITEDHEALTH GROUP INC | 9.3% | 9.0% | 9.0% |
|
JOHNSON & JOHNSON | 8.4% | 8.2% | 8.2% |
|
ABBVIE INC | 5.8% | 5.6% | 5.6% |
|
ELI LILLY & CO | 5.5% | 5.7% | 5.5% |
|
MERCK & CO. INC. | 5.6% | 5.4% | 5.4% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to IYH
|
CVS CAREMARK CORP | 2.1% |
|
MCKESSON CORP | 1.0% |
 |
METTLER-TOLEDO INTERNATIONAL | 0.7% |
|
AMERISOURCEBERGEN CORP | 0.5% |
|
WATERS CORP | 0.4% |
|
UNITEDHEALTH GROUP INC | 0.3% |
|
JOHNSON & JOHNSON | 0.2% |
|
MERCK & CO. INC. | 0.2% |
|
ABBVIE INC | 0.2% |
|
ABBOTT LABORATORIES | 0.2% |
XLV Underweight Relative to IYH
|
SEATTLE GENETICS INC | -0.6% |
|
HORIZON PHARMA PLC | -0.5% |
|
VEEVA SYSTEMS INC-CLASS A | -0.5% |
|
ALNYLAM PHARMACEUTICALS INC | -0.5% |
|
BIOMARIN PHARMACEUTICAL INC | -0.3% |
|
ROYALTY PHARMA PLC CLASS A | -0.3% |
|
AVANTOR, INC. | -0.3% |
|
EXACT SCIENCES CORP | -0.2% |
|
QIAGEN NV | -0.2% |
|
SAREPTA THERAPEUTICS INC | -0.2% |